HomeCompareACRTX vs PM

ACRTX vs PM: Dividend Comparison 2026

ACRTX yields 14.25% · PM yields 3.49%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ACRTX wins by $1.3K in total portfolio value
10 years
ACRTX
ACRTX
● Live price
14.25%
Share price
$14.04
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$51.0K
Annual income
$3,441.57
Full ACRTX calculator →
PM
Philip Morris International
● Live price
3.49%
Share price
$164.83
Annual div
$5.76
5Y div CAGR
17.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.6K
Annual income
$2,502.61
Full PM calculator →

Portfolio growth — ACRTX vs PM

📍 ACRTX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodACRTXPM
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ACRTX + PM cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ACRTX pays
PM pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ACRTX
Annual income on $10K today (after 15% tax)
$1,210.83/yr
After 10yr DRIP, annual income (after tax)
$2,925.33/yr
PM
Annual income on $10K today (after 15% tax)
$297.03/yr
After 10yr DRIP, annual income (after tax)
$2,127.22/yr
At 15% tax rate, ACRTX beats the other by $798.12/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ACRTX + PM for your $10,000?

ACRTX: 50%PM: 50%
100% PM50/50100% ACRTX
Portfolio after 10yr
$50.3K
Annual income
$2,972.10/yr
Blended yield
5.91%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PM right now

ACRTX
No analyst data
PM
Analyst Ratings
17
Buy
7
Hold
1
Sell
Consensus: Buy
Price Target
$194.30
+17.9% upside vs current
Range: $180.00 — $205.00
Altman Z
4.0
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ACRTX buys
0
PM buys
5
PoliticianChamberTickerTypeAmountDate
Julia Letlow🏢 House$PM▼ Sell$1,001 - $15,0002026-02-05
Julie Johnson🏢 House$PM▼ Sell$1,001 - $15,0002025-12-18
Julie Johnson🏢 House$PM▼ Sell$1,001 - $15,0002025-11-13
Ro Khanna🏢 House$PM▼ Sell$1,001 - $15,0002025-10-30
Ro Khanna🏢 House$PM▼ Sell$1,001 - $15,0002025-10-30
Ro Khanna🏢 House$PM▲ Buy$1,001 - $15,0002025-09-29
Ro Khanna🏢 House$PM▲ Buy$15,001 - $50,0002025-09-05
Ro Khanna🏢 House$PM▲ Buy$15,001 - $50,0002025-08-26
Julie Johnson🏢 House$PM▼ Sell$1,001 - $15,0002025-08-14
Julie Johnson🏢 House$PM▼ Sell$1,001 - $15,0002025-07-22
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricACRTXPM
Forward yield14.25%3.49%
Annual dividend / share$2.00$5.76
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%17.2%
Portfolio after 10y$51.0K$49.6K
Annual income after 10y$3,441.57$2,502.61
Total dividends collected$23.9K$11.8K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: ACRTX vs PM ($10,000, DRIP)

YearACRTX PortfolioACRTX Income/yrPM PortfolioPM Income/yrGap
1← crossover$12,125$1,424.50$11,650$409.56+$475.00ACRTX
2$14,587$1,614.15$13,592$497.49+$995.00ACRTX
3$17,423$1,814.98$15,882$605.21+$1.5KACRTX
4$20,669$2,026.03$18,589$737.41+$2.1KACRTX
5$24,362$2,246.21$21,794$899.94+$2.6KACRTX
6$28,542$2,474.34$25,597$1,100.16+$2.9KACRTX
7$33,249$2,709.21$30,118$1,347.30+$3.1KACRTX
8$38,526$2,949.55$35,505$1,652.97+$3.0KACRTX
9$44,417$3,194.09$41,940$2,031.88+$2.5KACRTX
10$50,968$3,441.57$49,643$2,502.61+$1.3KACRTX

ACRTX vs PM: Complete Analysis 2026

ACRTXStock

The investment seeks long-term capital appreciation. Under normal circumstances, the fund invests at least 80% of its assets in common stocks and other equity securities of small-cap companies. Small-cap companies are those with a market capitalization at the time of purchase of less than $5 billion or otherwise within the range of capitalizations of companies in the Russell 2000 ®Index, the S&P Small Cap 600 Index, or the Dow Jones U.S. Small-Cap Total Stock Market Index. It may also invest in real estate investment trusts (“REITs”).

Full ACRTX Calculator →

PMConsumer Staples

Philip Morris International Inc. operates as a tobacco company working to delivers a smoke-free future and evolving portfolio for the long-term to include products outside of the tobacco and nicotine sector. The company's product portfolio primarily consists of cigarettes and smoke-free products, including heat-not-burn, vapor, and oral nicotine products that are sold in markets outside the United States. The company offers its smoke-free products under the HEETS, HEETS Creations, HEETS Dimensions, HEETS Marlboro, HEETS FROM MARLBORO, Marlboro Dimensions, Marlboro HeatSticks, Parliament HeatSticks, and TEREA brands, as well as the KT&G-licensed brands, Fiit, and Miix. It also sells its products under the Marlboro, Parliament, Bond Street, Chesterfield, L&M, Lark, and Philip Morris brands. In addition, the company owns various cigarette brands, such as Dji Sam Soe, Sampoerna A, and Sampoerna U in Indonesia; and Fortune and Jackpot in the Philippines. The company sells its smoke-free products in 71 markets. Philip Morris International Inc. was incorporated in 1987 and is headquartered in New York, New York.

Full PM Calculator →
📬

Get this ACRTX vs PM comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ACRTX vs SCHDACRTX vs JEPIACRTX vs OACRTX vs KOACRTX vs MAINACRTX vs MOACRTX vs BTIACRTX vs PEP

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.